Toagosei Co., Ltd.

Toagosei Co., Ltd.

11.00
USD
+0.27
(+2.54%)
1.11BMarket Cap
Oct 30Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1,146.42
1,130.55
1,062.16
1,028.37
1,099.28
1,140.04
1,101.26
1,022.85
1,227.46
1,304.03
1,344.93
1,475.43
1,487.84
- -
Basic EPS, GAAP
72.88
63.88
50.86
104.83
98.08
96.85
78.91
62.43
108.14
101.31
102.78
104.56
117.02
- -
Free Cash Flow per Basic Share
84.27
54.99
141.71
118.81
66.68
62.09
25.13
47.49
76.19
-75.46
84.2
-21.29
-83.64
- -
Dividend per Share
19.99
22.04
23.99
24.95
25.99
26.99
29.04
30.15
32.18
37.29
38.42
63.89
63.46
- -
Book Value per Share
1,090.9
1,159.64
1,201.45
1,276.08
1,387.34
1,416.22
1,472.08
1,505.68
1,613.88
1,700.74
1,816.09
1,897.59
2,002.19
2,079.69
Tangible Book Value per Share
1,084.71
1,155.26
1,197.74
1,272.29
1,383.5
1,411.36
1,466.56
1,499.56
1,600.53
1,687.6
1,802.53
1,882.72
1,958.17
2,035.32
Basic Weighted Avg Shares
132
132
132
132
132
132
132
130
127
123
118
114
109
107
Sales/Revenue/Turnover
151,081
148,912
139,848
135,382
144,708
150,066
144,955
133,392
156,313
160,825
159,371
167,594
162,312
- -
Operating Margin (%)
9.6
8.07
8.83
11.93
12.06
10.93
9.51
9.25
11.31
8.94
7.84
8.49
8.74
- -
Depreciation Expense
7,654
8,677
8,866
7,974
7,944
8,374
9,257
9,848
10,623
10,457
10,656
11,302
11,652
- -
Net Income, GAAP
9,605
8,414
6,696
13,801
12,911
12,748
10,387
8,142
13,771
12,494
12,179
11,877
12,766
- -
Effective Tax Rate (%)
32.97
33.87
40.23
31.28
29.13
25.91
30.31
31.74
25.64
26.34
28.44
27.72
25.97
- -
Profit Margin (%)
6.36
5.65
4.79
10.19
8.92
8.49
7.17
6.1
8.81
7.77
7.64
7.09
7.87
- -
Working Capital
67,447
76,918
85,719
99,591
100,241
107,019
106,048
98,039
108,431
101,193
93,380
73,997
63,180
59,614
LT Debt
5,986
10,457
10,048
9,886
5,735
9,283
9,282
4,700
8,870
9,727
9,672
5,896
14,744
13,700
Total Equity
148,147
157,348
163,018
173,000
187,485
191,294
198,578
197,640
206,610
210,806
212,517
213,667
215,943
220,993
Return on Invested Capital (%)
6.14
4.74
4.22
6.03
6.32
5.96
4.59
3.98
6.07
4.74
3.95
4.51
4.48
- -
Return on Capital (%)
6.08
4.94
3.67
7.45
6.56
6.26
4.92
3.8
6.38
5.58
5.46
5.28
5.55
- -
Return on Common Equity (%)
6.97
5.68
4.31
8.46
7.36
6.91
5.46
4.21
6.98
6.13
5.83
5.6
5.97
- -

Capital Structure

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
ST Debt
6,220
- -
6,865
LT Borrowings
4,930
- -
13,700
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
113
106
106
Market Capitalization
- -
191,771
180,970

Working Capital

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
Total Current Assets
129,895
- -
107,424
Cash, Cash Equivalents & STI
51,038
- -
22,017
Accounts Receivable, Net
50,135
- -
38,543
Inventories
25,591
- -
28,462
Total Current Liabilities
47,133
- -
47,810
Payables & Accruals
- -
- -
- -
ST Debt
6,220
- -
6,865
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.88%
1.8%
1.07%
Free Cash Flow
-23.26%
-38.66%
277.38%
Net Income, GAAP
12.06%
12.47%
7.49%
Sales/Revenue/Turnover
1.72%
4.24%
-3.15%
Total Cash Common Dividend
9.27%
14.05%
-4.6%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
39,014
42,557
- -
- -
167,594
2025
- -
- -
- -
- -
162,312
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
23.6
38.1
- -
- -
104.56
2025
- -
- -
- -
- -
117.02
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
63.89
2025
- -
- -
- -
- -
63.46
2026
- -
- -
- -
- -
- -

Company Description

CEO
Mikishi Takamura
Full Time Employees
2,680
Sector
Process industries
Industry
Chemicals: specialty
Address
1-14-1 Nishi-Shimbashi Tokyo Japan 105-8419
IPO Date
May 16, 1949
Business
Toagosei Co., Ltd. manufactures and sells a broad range of chemical products, operating through Commodity Chemicals; Polymer & Oligomer; Adhesive Material; Performance Chemicals; Plastics; and Other segments. The company produces commodity chemicals such as liquid caustic soda, liquid chlorine, synthetic hydrochloric acid, sodium hypochlorite, caustic potash, sulfuric acid, sodium sulfite, potassium pyrophosphate, copper oxide, iron perchloride, hypochlorous acid, copper pyrophosphate, copper potassium pyrophosphate, chlorinated solvents including trichloroethylene and tetrachloroethylene, ammonium sulfate, potassium bicarbonate fertilizers, industrial gases like oxygen, nitrogen, argon, hydrogen, carbon dioxide and mixed gases; polymers and oligomers encompassing acrylic acid, acrylic esters, acrylic monomers, acrylamide tertiary butyl sulfonic acid, ethylene carbonate, acrylic polymers including dispersants, thickeners, scale inhibitors, pressure sensitive adhesives, binders, paint vehicles, gelling agents, graft polymers, ARUFON and macromonomers, special polymers, solvent-free acrylic polymers, special acrylic monomers, polymer flocculants and UV-curable resins; adhesive materials such as instant glue (Aron Alpha), functional adhesives, accessories, silsesquioxane derivatives, powder paints; performance chemicals including liquid hydrogen chloride, hexachlorodisilane, potassium hydroxide and carbonate aqueous solutions, ferric chloride solutions, inorganic functional materials for environmental amenity and electronics; and plastics products like piping equipment, nursing care products, elastomeric compounds and environmental preservation systems. Founded in 1944 and headquartered at 1-14-1 Nishi-Shimbashi, Minato-ku, Tokyo, Japan, Toagosei conducts operations in Japan, the United States, China, Taiwan, Hong Kong, India and internationally, serving industries including semiconductors, electronics, automotive, construction, civil engineering and medical. Recent developments include the establishment of a local subsidiary in India in 2024; launch of independent instant adhesive operations in the U.S. in 2025; conclusion of a collaborative research agreement with Innovation Center of NanoMedicine on siRNA medication for triple-negative breast cancer treatment in 2025; endorsement of TNFD recommendations and participation in the TNFD Forum in 2025; announcement of the low-carbon hydrogen model town pilot project in Chita City, Aichi Prefecture in 2025; issuance of unsecured straight bonds in 2025; ongoing treasury stock acquisitions and cancellations to enhance shareholder returns; and participation in land-based salmon farming and low-carbon hydrogen feasibility studies in 2024.